^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

EMD 1204831

i
Other names: EMD 1204831
Associations
Trials
Company:
EMD Serono
Drug class:
c-MET inhibitor
Related drugs:
Associations
Trials
8ms
Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol. (PubMed, Int J Oncol)
Finally, kaempferol and EMD‑1204831 had an obvious inhibitory effect on the growth of GBM and sensitized GBM to cuproptosis inducers via COL22A1 in cell and animal experiments. Overall, the present study revealed a cuproptosis‑related combined regimen for GBM.
Journal
|
COL22A1 (Collagen Type XXII Alpha 1 Chain)
|
EMD 1204831